OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
16
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Publication Date
Release Date
2010
(4)
2023
(3)
2025
(2)
2022
(2)
2024
(1)
2021
(1)
2016
(1)
2011
(1)
2008
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Effects of combination lipid therapy in type 2 diabetes mellitus.
Not available
S-EPMC2879499
|
biostudies-literature
Cite
Effects of intensive blood-pressure control in type 2 diabetes mellitus.
Not available
S-EPMC4123215
|
biostudies-literature
Cite
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Not available
S-EPMC4123233
|
biostudies-literature
Cite
Effects of intensive glucose lowering in type 2 diabetes.
Not available
S-EPMC4551392
|
biostudies-literature
Cite
Effects of medical therapies on retinopathy progression in type 2 diabetes.
Not available
S-EPMC4026164
|
biostudies-literature
Cite
Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response.
Not available
S-EPMC5013254
|
biostudies-literature
Cite
Stratified analyses refine association between TLR7 rare variants and severe COVID-19.
Not available
S-EPMC11320601
|
biostudies-literature
Cite
Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical Trial.
Not available
S-EPMC12090071
|
biostudies-literature
Cite
Long-term effects of intensive glucose lowering on cardiovascular outcomes.
Not available
S-EPMC4083508
|
biostudies-literature
Cite
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Not available
S-EPMC10408259
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets